Business - BioPharm International



AbbVie Reconsiders Shire Offer

October 15, 2014

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

Marrying Big Data with Personalized Medicine

August 1, 2014

Data analytic strategies can help companies capitalize on personalized medicine.

AbbVie to Acquire Shire for $54.7 Billion

July 18, 2014

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Moving the Needle on Healthcare

July 1, 2014

Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.

Brazil's Phytotherapic Drug Market and Regulation

July 1, 2014

Is there potential for growth in Brazil's phytotherapic drug market?

NIH and NSF Collaborate on Biomedical Innovation

June 18, 2014

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

AstraZeneca Rejects Pfizer's Final Offer

May 19, 2014

AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.

Tigermed Acquires Frontage Laboratories

May 8, 2014

Tigermed acquires Frontage Laboratories for $50.25 million.

Sun Pharma to Acquire Ranbaxy

April 7, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.



Click here